Issue of Equity and Total Voting Rights Issue of Equity and

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
33
Issue of Equity and Total Voting Rights

Issue of Equity and Total Voting Rights

KINGS ARMS YARD VCT PLC

LEI Code 213800DK8H27QY3J5R45

The first allotment for the 2018/2019 tax year of new ordinary shares of nominal value 1 penny per share in Kings Arms Yard VCT PLC (the “Company”) under the Albion VCTs Prospectus Top Up Offers 2018/19 (the “Offers”), (which was launched on 7 January 2019) took place on 1 April 2019. 

Pursuant to the Prospectus, the Company offered a 1% discount on issue costs to existing shareholders and 0.5% discount on issue costs to new subscribers. These early bird discounts were available to investors who subscribed for new shares for the first £10m by 2 p.m. on 28 February 2019 across the six VCTs participating in the Offers. The cost of these discounts is being borne by the Manager, Albion Capital Group LLP. The issue pricing of the new shares has been calculated to avoid any capital dilution to existing shareholders who do not participate in the Offers.

The Company has received valid applications for 4,206,012 new ordinary shares which will be allotted at an issue price of 23.2 pence per share from existing shareholders and 943,355 new ordinary shares allotted at an issue price of 23.3 pence per share for new subscribers, both of which qualified for the early bird discount. A further 21,793,720 new ordinary shares will be allotted at an issue price of 23.4 pence per share (which did not qualify for the early bird discount). The total net proceeds receivable by the Company under these allotments is approximately £6,149,000.

Application has been made to the Financial Conduct Authority for 26,943,087 new ordinary shares to be admitted to the Official List and to the London Stock Exchange for the new ordinary shares to be admitted to trading on the London Stock Exchange's market for listed securities. The new ordinary shares rank pari passu with the existing shares in issue.

The record date in respect of the dividend of 0.6 pence per share to be paid on 30 April 2019 is 5 April 2019, and as a result, the new ordinary shares will qualify for this dividend.

It is expected that admission will become effective, and that dealings in the shares will commence on or before 8.00 a.m. on 4 April 2019.

The Offers constitute separate offers made by each of the Albion VCT's which are participating in it. As at 1 April 2019, the amount raised in total across the Albion VCTs under the Offers was £44m (of which £2.5m relates to tax year 2019/2020) and the Offers will remain open until 2 p.m. on 30 September 2019 (unless fully subscribed before this date).

Following this allotment and in conformity with the provisions of DTR 5.6, we make the following notifications in connection with the issued share capital of the Company:

The Company's capital as at 1 April 2019 consists of 378,798,860 ordinary shares with a nominal value of 1 penny each. The Company holds 49,170,000 ordinary shares in Treasury.

Therefore, the total number of voting rights in the Company is 329,628,860 which may be used by shareholders and other persons as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

For further information, please contact:

Albion Capital Group LLP
Company Secretary
020 7601 1850
2 April 2019

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lawyers Juggle AI's Promise and Perils in 2026

Updated Category News Views 104

AI's Growing Pains in the Legal Arena Looks like the legal eagles are getting a run for their money with AI entering the courtroom. Bloomberg Law's 2026 AI in Practice report dives deep into this legal labyrinth. You got attorneys leaning on AI to keep the gears turning, but they're also clutching their pearls over potential pitfalls. Trust Issues: Humans vs. Machines The...

Continue Reading
Siemens Set to Acquire Lauterbach in Strategic Move

Updated Category News Views 81

Siemens Seizing New Opportunities with Lauterbach Acquisition Bam! Siemens is on the move, folks, snapping up Lauterbach to bolster its semiconductor design arsenal. Now, if you’ve got your eyes glued to innovation in chip design, like yours truly, then strap in because this merger is more than just a footnote on some dusty tech page. It's a game-changer when it comes...

Continue Reading
Jinko Solar Joins B20 Summit: Energy Forefront Focus

Updated Category News Views 145

Jinko Solar's Invitation to the B20 Summit Never a dull moment in the solar space, especially when Jinko Solar, a big shot in clean energy, jumps into the spotlight at the B20 Summit in the U.S. Awash with high-profile discussions, Jinko's not just chatting—it's the only photovoltaic firm strutting its stuff in D.C. with gutsy calls for energy reform. Key Takeaways from...

Continue Reading
Paulex Bio's Grant Fuels Bold Diabetes Research Push

Updated Category News Views 89

Cracking the Diabetes Code: A New Hope Emerging It ain't every day you hear about a biotech outfit snagging an NIH Fast-Track grant with the potential to upend diabetes treatment, but Paulex Bio's recent score turns heads. Their brainchild, PAL-119, promises to tackle diabetes not by slapping a band-aid on symptoms, but by getting to the rotten core of the disease: the...

Continue Reading
Shukla MD's New Concierge Program Boosts Patient Care

Updated Category News Views 63

Shifting the Healthcare Paradigm Imagine a healthcare world where doctors actually have the time to listen and engage with you beyond just scribbling notes in haste. That's what's brewing over in Westchester, where Dr. Rachana and Dr. Vaishalee Shukla are putting the old-school patient-doctor relationship front and center with their Hybrid Choice concierge program. Run...

Continue Reading
NHTSA, Ad Council Unveil New Anti-Buzzed Driving PSAs

Updated Category News Views 71

Taking Aim at a Deadly Habit Everyone's got that gut feeling when a day-long meeting runs over or you're stuck in traffic — impatience morphed with slow burn menace. Now picture a whole campaign gunning for that vibe but in the hands of the young folks, those from 21 to 34. That's what we're talking about here, with the Ad Council and NHTSA serving up some fresh public...

Continue Reading
Cognizant Boosts Claude AI with 25,000 Pro Workforce

Updated Category News Views 157

Moving AI from Theory to Practice You know, AI isn't about just keeping up with the hype; it's about shoving those algorithms right where they can do the most good—right at the core of business operations. And that’s precisely what Cognizant's cooking up with their fresh-off-the-press Claude Frontier Capability Group. They’ve thrown more than 25,000 pros into the...

Continue Reading
Bandwidth's SI Innovations: A New Dawn or Just Hype?

Updated Category News Views 56

Bandwidth Unleashes Super Intelligence at Reverb Right off the bat, Bandwidth's Reverb showcase was enough to stir up some excitement in the air. The company laid out a feast of technological advancements with their Super Intelligence (SI) innovations that claim to redefine how enterprises communicate. But here's the rub—while these developments sound thrilling, the...

Continue Reading
Parachute Health Urges HME Transformation Through Collaboration

Updated Category News Views 159

The Road to Digital Unity in HME Cranking through the gears of the healthcare industry is no mean feat, but Parachute Health seems ready to throw some fresh oil on the machine. In a landscape riddled with complexities, they're sounding the call for a more unified digital infrastructure in the Home Medical Equipment (HME) sector through their latest white paper. We're...

Continue Reading
What's at Stake: Pearl Diver's Q3 2026 Earnings Call

Updated Category News Views 60

Upcoming Unveiling: Pearl Diver's Latest Financials Heads up, folks. November 16 can't come soon enough for those keeping tabs on Pearl Diver Credit Company Inc. (NYSE: PDCC, PDPA). The bigwigs over there are planning to spill the beans on their third quarter 2026 financial results. They'll kick things off before the market even has its first cup of java on Monday morning...

Continue Reading

Top 5 Most Recently Viewed Articles

Boardwalktech Software to Showcase Innovations at Upcoming Event

Updated Category News Views 161

Boardwalktech Software Demonstrates Commitment to Innovation Boardwalktech Software Corp. (TSXV: BWLK) (OTCQB: BWLKF), recognized as a leader in the Intelligent Information Platform sector, has announced that their CEO and Chairman, Andrew Duncan, is set to present at the highly anticipated Planet MicroCap Showcase. This event, in partnership with MicroCapClub, serves as...

Continue Reading
Sabio Holdings' Creator Television® Earns Top Newcomer Award

Updated Category News Views 136

Sabio Holdings' Creator Television® Triumphs at Industry Awards In an impressive early success, Creator Television®, a project of Sabio Holdings, has clinched the 'Most Significant Newcomer' award at the InteractiveTV Today (ITVT) Awards. This recognition comes as a significant milestone for the company during Creator TV's first six months since launch. An Award for...

Continue Reading
Starbucks Corporation Under Investigation by Kahn Swick & Foti

Updated Category News Views 344

Starbucks Corporation Faces Investigation In recent developments, Kahn Swick & Foti, LLC has started an investigation regarding Starbucks Corporation (NASDAQ: SBUX). Led by former Louisiana Attorney General Charles C. Foti, Jr., this inquiry raises important questions about the company and its executives. Financial Performance Raises Red Flags Starbucks' recent financial...

Continue Reading
Innovative Nitric Oxide Therapy Shows Promise in Cancer Treatment

Updated Category News Views 213

Exploring the Efficacy of LV UNO Therapy in Cancer Treatment Beyond Cancer, Ltd. has introduced groundbreaking preclinical data showcasing the benefits of Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) therapy. This therapy, when combined with immune checkpoint inhibitors, demonstrates significant potential for enhancing patient outcomes in cancer treatments....

Continue Reading
Wabash Partners with Decisiv to Enhance Service Management

Updated Category News Views 305

Wabash and Decisiv Forge a New Partnership Wabash, a leading provider of innovative supply chain solutions, has formed a strategic partnership with Decisiv to enhance service management capabilities within its dealer network. This collaboration aims to streamline service event management and improve uptime for Wabash customers. Decisiv's Impact on Service Management The...

Continue Reading